Home/Filings/4/0001179110-19-002935
4//SEC Filing

Sagartz John E 4

Accession 0001179110-19-002935

CIK 0000720154other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 5:16 PM ET

Size

8.8 KB

Accession

0001179110-19-002935

Insider Transaction Report

Form 4
Period: 2019-02-19
Sagartz John E
DirectorChief Strategy Officer
Transactions
  • Small Acquisition

    Common Shares

    2019-02-19$1.43/sh+2,500$3,5752,500 total
Holdings
  • Common Shares

    (indirect: See Footnote)
    617,625
Footnotes (1)
  • [F1]The Reporting Person owns 41.175% of the outstanding equity interests of SW Chrysalis, LLC, a Delaware limited liability company, which owns 1,500,000 common shares of the Issuer. The Reporting Person is Co-President and Chief Strategy Officer of SW Chrysalis, LLC.

Issuer

BIOANALYTICAL SYSTEMS INC

CIK 0000720154

Entity typeother

Related Parties

1
  • filerCIK 0001746201

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:16 PM ET
Size
8.8 KB